{
    "code": "02021051",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021051",
    "time": "2020-02-25 12:36:42",
    "許可證字號": "衛署藥輸字第021051號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/08\/16",
    "註銷理由": "屆期未申請展延",
    "製造許可登錄編號": "",
    "有效日期": "89\/09\/25",
    "發證日期": "84\/09\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202105101",
    "中文品名": "必除癌注射液５０公絲",
    "英文品名": "ABITREXATE FOR INJECTION 50MG\/VIAL",
    "適應症": "白血病、絨毛性腫瘍之自覺及他覺症狀之緩解",
    "劑型": "243凍晶注射劑",
    "包裝": "小瓶 盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "METHOTREXATE ANHYDROUS",
    "限制項目": "02輸　入",
    "申請商名稱": "1223901100  華特實業股份有限公司",
    "申請商地址": "台北巿大同區依寧街7之1號一樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIL0010000  ABIC LTD., PHARMACEUTICAL &amp; CHEMICAL INDUSTRIES",
            "製造廠廠址": "HATRUFA STREET INDUSTRIAL ZONE, P.O.B. 8077, NETANYA, ISRAEL",
            "製造廠公司地址": "",
            "製造廠國別": "ISRAEL",
            "製程": ""
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1008200150",
            "成分名稱": "METHOTREXATE ANHYDROUS",
            "含量描述": "50",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ]
}